Filing Details

Accession Number:
0001181431-13-015986
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-11 16:24:09
Reporting Period:
2013-03-07
Filing Date:
2013-03-11
Accepted Time:
2013-03-11 16:24:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021038 A Henri Termeer C/O Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-07 55,499 $6.73 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $6.70 to $6.735. The reporting person undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.